SHORT LEVERAGE - GSK PLC Stock

Certificat

SGSKS5

DE000SW8FYD7

Market Closed - Borsa Italiana 04:04:59 2024-05-21 pm EDT
14.22 EUR +5.49% Intraday chart for SHORT LEVERAGE - GSK PLC
Current month-26.17%
1 month-40.03%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart SHORT LEVERAGE - GSK PLC
Date Price Change
24-05-21 14.22 +5.49%
24-05-20 13.48 -0.88%
24-05-17 13.6 +2.72%
24-05-16 13.24 +4.33%
24-05-15 12.69 +1.76%

Real-time Borsa Italiana

Last update May 21, 2024 at 04:04 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying GSK PLC
IssuerLogo Issuer Société Générale Société Générale
SGSKS5
ISINDE000SW8FYD7
Date issued 2024-04-08
Maturity Unlimited
Parity 1 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 26.25
Lowest since issue 12.34
Spread 0.67
Spread %4.60%

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
17.56 GBP
Average target price
20.32 GBP
Spread / Average Target
+15.73%
Consensus
  1. Stock Market
  2. Certificates
  3. SGSKS5 Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW